Le point sur la cession de BF&M
28 Mars 2024
Camélia Plc
(la « Société » ou le « Groupe »)
Le point sur la cession de BF&M
As announced in June 2023, we agreed the sale of our 37% holding in BF&M to Bermuda Life Insurance Company Limited, a subsidiary of Argus Group Holdings Limited ("Argus") for a cash consideration of $100m (the "Sale"), conditional on receipt of a number of regulatory and tax approvals.
Following the announcement of this proposed disposal, BF&M's board implemented a shareholder rights agreement, the objective of which was to act as a 'poison pill' in the event of any new shareholder seeking to register a more than 15% shareholding without BF&M's consent. This shareholder rights agreement has since been removed. However, BF&M thereafter separately announced a partnership with Equilibria Capital Management Limited (Argus' major shareholder) under which Equilibria will grant BF&M an exclusive option to acquire a 13.7% stake in Argus. As part of this partnership, BF&M has also committed to a significant investment in a dedicated Equilibria investment fund which will include as its initial investment a 16.3% stake in Argus.
As previously communicated, these developments have impacted the anticipated timetable for regulatory approvals for the Sale. While a number of the required regulatory and tax approvals have been forthcoming, some key approvals remain outstanding which we now expect in Q2 2024.
Cette annonce contient des informations privilégiées aux fins du règlement britannique sur les abus de marché.
Demandes de renseignements
Camélia Plc +01622 (746655)XNUMX XNUMX
Byron Coombs, CEO
Suzanne Walker, chef De la direction financière
Panmure Gordon +020 (7886)2500
Conseiller désigné et Broker
Emma Comte
Rupert Deard
Conseillers H/Maitland
PR
William Clutterbuck 07785 292617
RNS peut utiliser votre adresse IP pour confirmer le respect des termes et conditions, pour analyser votre interaction avec les informations contenues dans cette communication et pour partager cette analyse de manière anonyme avec d'autres dans le cadre de nos services commerciaux. Pour plus d'informations sur la manière dont RNS et la Bourse de Londres utilisent les données personnelles que vous nous fournissez, veuillez consulter notre Politique de confidentialité.